A drug trafficker organizes an operation to smuggle fentanyl between Canada and the United States; an architect recovering from oxycodone addiction seeks the truth about his son’s involvement with a drug cartel; and a university professor grapples with unexpected revelations about his employer — an influential pharmaceutical company that is bringing a new “non‑addictive” painkiller to market.